QIAGEN N.V.: Release according to Article 30e of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
QIAGEN N.V. hereby announces that a Form 6-K Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for the month ended December 31, 2017 was filed with the United States Securities and Exchange Commission (SEC) providing notice to the NASDAQ Global Select Market that the Company intends to voluntarily delist its common shares, par value EUR 0.01 per share, from NASDAQ, intends to subsequently list such common shares on the New York Stock Exchange (NYSE).
The document is now available on the website of QIAGEN: https://corporate.qiagen.com/investor-relations/financial-reports#docs_o=R eport Release Date,Descending&docs_Report Release Date=
12.12.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: QIAGEN N.V. Hulsterweg 82 5912 PL Venlo
Netherlands Internet: www.qiagen.com End of News DGAP News Service